Impact of Pneumonia in Heart Failure Patients

Affiliations

¹ Zena and Michael A. Weiner Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: donna.mancini@mountsinai.org.
² Zena and Michael A. Weiner Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Editorial

Donna Mancini et al. J Am Coll Cardiol. 2021.

. 2021 Apr 27;77(16):1974-1976.

doi: 10.1016/j.jacc.2021.03.010.

¹ Zena and Michael A. Weiner Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: donna.mancini@mountsinai.org.
² Zena and Michael A. Weiner Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

No abstract available

Keywords: heart failure; incidence; pneumonia; risk; vaccination.

Conflict of interest statement

Funding Support and Author Disclosures Both authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Incidence and Outcomes of Pneumonia in Patients With Heart Failure.
Shen L, Jhund PS, Anand IS, Bhatt AS, Desai AS, Maggioni AP, Martinez FA, Pfeffer MA, Rizkala AR, Rouleau JL, Swedberg K, Vaduganathan M, Vardeny O, van Veldhuisen DJ, Zannad F, Zile MR, Packer M, Solomon SD, McMurray JJV. Shen L, et al. J Am Coll Cardiol. 2021 Apr 27;77(16):1961-1973. doi: 10.1016/j.jacc.2021.03.001. J Am Coll Cardiol. 2021. PMID: 33888245 Clinical Trial.